Parkman Healthcare Partners
Latest statistics and disclosures from Parkman Healthcare Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BSX, PODD, UTHR, LLY, COO, and represent 22.73% of Parkman Healthcare Partners's stock portfolio.
- Added to shares of these 10 stocks: AGIO (+$19M), PODD (+$18M), MRK (+$12M), KNSA (+$12M), ICLR (+$12M), HUM (+$11M), BSX (+$9.7M), GILD (+$8.6M), BMY (+$8.3M), ITCI (+$7.9M).
- Started 14 new stock positions in ANAB, TERN, ICLR, MRK, AGIO, BMY, REPL, KNSA, GILD, AVDL. ENTX, RARE, HUM, BCRX.
- Reduced shares in these 10 stocks: THC (-$18M), INSP (-$17M), Silk Road Medical Inc Common (-$16M), COR (-$14M), Kiniksa Pharmaceuticals (-$13M), OSCR (-$12M), , Deciphera Pharmaceuticals (-$12M), TMO (-$9.1M), RXST (-$7.0M).
- Sold out of its positions in ABOS, Flamel Technologies Sa, BFLY, CNC, CRL, CGEM, CYTK, Deciphera Pharmaceuticals, IRON, ETNB. LAB, HCA, IDYA, INSP, INZY, LYRA, NKTX, OSCR, Silk Road Medical Inc Common, TMO, Kiniksa Pharmaceuticals, NVCR, SOPH.
- Parkman Healthcare Partners was a net seller of stock by $-37M.
- Parkman Healthcare Partners has $747M in assets under management (AUM), dropping by -8.40%.
- Central Index Key (CIK): 0001777015
Tip: Access up to 7 years of quarterly data
Positions held by Parkman Healthcare Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 90 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Boston Scientific Corporation (BSX) | 5.7 | $43M | +29% | 552k | 77.01 |
|
| Insulet Corporation (PODD) | 4.8 | $36M | +97% | 179k | 201.80 |
|
| United Therapeutics Corporation (UTHR) | 4.8 | $36M | -13% | 111k | 318.55 |
|
| Eli Lilly & Co. (LLY) | 3.8 | $29M | 32k | 905.38 |
|
|
| Cooper Cos (COO) | 3.6 | $27M | +8% | 308k | 87.30 |
|
| Tenet Healthcare Corp Com New (THC) | 2.7 | $20M | -47% | 149k | 133.03 |
|
| Agios Pharmaceuticals (AGIO) | 2.6 | $19M | NEW | 446k | 43.12 |
|
| Longboard Pharmaceuticals In (LBPH) | 2.5 | $19M | 694k | 27.03 |
|
|
| Rxsight (RXST) | 2.4 | $18M | -28% | 297k | 60.17 |
|
| Dex (DXCM) | 2.4 | $18M | -8% | 157k | 113.38 |
|
| Becton, Dickinson and (BDX) | 2.1 | $16M | +49% | 68k | 233.71 |
|
| Neurocrine Biosciences (NBIX) | 2.1 | $16M | -12% | 115k | 137.67 |
|
| Anthem (ELV) | 2.0 | $15M | +83% | 28k | 541.86 |
|
| Schrodinger (SDGR) | 1.9 | $14M | -27% | 721k | 19.34 |
|
| Intra Cellular Therapies (ITCI) | 1.7 | $13M | +164% | 185k | 68.49 |
|
| Abbott Laboratories (ABT) | 1.7 | $13M | 122k | 103.91 |
|
|
| Mannkind Corp Com New (MNKD) | 1.7 | $13M | 2.4M | 5.22 |
|
|
| Day One Biopharmaceuticals I (DAWN) | 1.7 | $13M | +31% | 909k | 13.78 |
|
| Merck & Co Put Option (MRK) | 1.7 | $12M | NEW | 100k | 123.80 |
|
| Syndax Pharmaceuticals (SNDX) | 1.7 | $12M | -23% | 601k | 20.53 |
|
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 1.6 | $12M | NEW | 647k | 18.67 |
|
| Icon SHS (ICLR) | 1.6 | $12M | NEW | 37k | 313.47 |
|
| Vaxcyte (PCVX) | 1.5 | $11M | 150k | 75.51 |
|
|
| Humana (HUM) | 1.5 | $11M | NEW | 30k | 373.65 |
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 1.5 | $11M | +2% | 535k | 20.24 |
|
| Edgewise Therapeutics (EWTX) | 1.4 | $10M | -12% | 575k | 18.01 |
|
| Nurix Therapeutics (NRIX) | 1.3 | $9.9M | +89% | 475k | 20.87 |
|
| Qiagen Nv Shs New (QGEN) | 1.3 | $9.6M | -25% | 234k | 41.09 |
|
| Inari Medical Ord (NARI) | 1.3 | $9.4M | +56% | 196k | 48.15 |
|
| Keros Therapeutics (KROS) | 1.2 | $9.1M | +11% | 199k | 45.70 |
|
| Alphatec Hldgs Com New (ATEC) | 1.2 | $8.9M | +153% | 852k | 10.45 |
|
| Arcellx Common Stock (ACLX) | 1.2 | $8.7M | 157k | 55.19 |
|
|
| Verona Pharma Sponsored Ads (VRNA) | 1.2 | $8.6M | +12% | 595k | 14.46 |
|
| Gilead Sciences (GILD) | 1.1 | $8.6M | NEW | 125k | 68.61 |
|
| AmerisourceBergen (COR) | 1.1 | $8.6M | -61% | 38k | 225.30 |
|
| Bristol Myers Squibb (BMY) | 1.1 | $8.3M | NEW | 200k | 41.53 |
|
| Xenon Pharmaceuticals (XENE) | 1.1 | $8.2M | -6% | 209k | 38.99 |
|
| Travere Therapeutics (TVTX) | 1.1 | $8.0M | 970k | 8.22 |
|
|
| Ionis Pharmaceuticals (IONS) | 1.0 | $7.7M | +14% | 162k | 47.66 |
|
| Anaptysbio Inc Common (ANAB) | 0.9 | $6.4M | NEW | 256k | 25.06 |
|
| Crinetics Pharmaceuticals In (CRNX) | 0.8 | $6.3M | +39% | 141k | 44.79 |
|
| Arcus Biosciences Incorporated (RCUS) | 0.8 | $6.3M | +59% | 416k | 15.23 |
|
| Haemonetics Corporation (HAE) | 0.8 | $6.3M | -16% | 76k | 82.73 |
|
| Castle Biosciences (CSTL) | 0.8 | $6.0M | -24% | 278k | 21.77 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.8 | $5.8M | -21% | 354k | 16.25 |
|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.8 | $5.7M | +3% | 876k | 6.52 |
|
| Silence Therapeutics Ads (SLN) | 0.7 | $5.5M | +18% | 290k | 19.00 |
|
| Insmed Com Par $.01 (INSM) | 0.7 | $5.4M | -13% | 80k | 67.00 |
|
| CVRX (CVRX) | 0.7 | $5.4M | +34% | 448k | 11.99 |
|
| Applied Therapeutics (APLT) | 0.7 | $5.4M | -38% | 1.1M | 4.67 |
|
| Avadel Pharmaceuticals Com Shs (AVDL) | 0.7 | $5.3M | NEW | 378k | 14.06 |
|
| Sutro Biopharma (STRO) | 0.7 | $5.3M | 1.8M | 2.93 |
|
|
| Amicus Therapeutics (FOLD) | 0.7 | $5.0M | +121% | 503k | 9.92 |
|
| Replimune Group (REPL) | 0.6 | $4.7M | NEW | 525k | 9.00 |
|
| Performant Finl (PFMT) | 0.6 | $4.7M | -2% | 1.6M | 2.90 |
|
| Livanova SHS (LIVN) | 0.6 | $4.7M | -41% | 85k | 54.82 |
|
| Urogen Pharma (URGN) | 0.6 | $4.6M | +49% | 275k | 16.78 |
|
| Veracyte (VCYT) | 0.6 | $4.5M | -17% | 210k | 21.67 |
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.6 | $4.5M | 101k | 43.97 |
|
|
| Peregrine Pharmaceuticals (CDMO) | 0.6 | $4.4M | +129% | 621k | 7.14 |
|
| Ultragenyx Pharmaceutical (RARE) | 0.6 | $4.1M | NEW | 100k | 41.10 |
|
| Fortrea Hldgs Common Stock (FTRE) | 0.5 | $3.6M | -64% | 153k | 23.34 |
|
| Arvinas Ord (ARVN) | 0.4 | $3.3M | 125k | 26.62 |
|
|
| Nuvalent Inc-a (NUVL) | 0.4 | $3.3M | -10% | 43k | 75.86 |
|
| Tg Therapeutics (TGTX) | 0.4 | $3.2M | +16% | 180k | 17.79 |
|
| Ventyx Biosciences (VTYX) | 0.4 | $2.7M | -3% | 1.2M | 2.31 |
|
| Merus N V (MRUS) | 0.4 | $2.7M | -43% | 45k | 59.17 |
|
| Terns Pharmaceuticals (TERN) | 0.4 | $2.7M | NEW | 390k | 6.81 |
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.3 | $2.6M | -32% | 135k | 19.21 |
|
| Esperion Therapeutics (ESPR) | 0.3 | $2.5M | 1.1M | 2.22 |
|
|
| BioCryst Pharmaceuticals (BCRX) | 0.3 | $2.5M | NEW | 400k | 6.18 |
|
| Dynavax Technologies Corp Com New (DVAX) | 0.3 | $2.4M | -18% | 217k | 11.23 |
|
| Quanterix Ord (QTRX) | 0.3 | $2.3M | 176k | 13.21 |
|
|
| Si-bone (SIBN) | 0.3 | $2.0M | 153k | 12.93 |
|
|
| Elanco Animal Health (ELAN) | 0.2 | $1.8M | -37% | 126k | 14.43 |
|
| Third Harmonic Bio (THRD) | 0.2 | $1.7M | +233% | 133k | 13.00 |
|
| Annexon (ANNX) | 0.2 | $1.6M | -5% | 327k | 4.90 |
|
| Essa Pharma Com New (EPIX) | 0.2 | $1.3M | 252k | 5.26 |
|
|
| Ardelyx (ARDX) | 0.1 | $1.1M | -24% | 150k | 7.41 |
|
| Viking Therapeutics (VKTX) | 0.1 | $1.1M | -32% | 20k | 53.01 |
|
| Akoya Biosciences (AKYA) | 0.1 | $879k | -59% | 376k | 2.34 |
|
| Eton Pharmaceuticals (ETON) | 0.1 | $833k | +27% | 253k | 3.29 |
|
| Entera Bio SHS (ENTX) | 0.1 | $739k | NEW | 402k | 1.84 |
|
| Vyne Therapeutics (VYNE) | 0.1 | $680k | -50% | 345k | 1.97 |
|
| Reviva Pharmaceutcls Hldgs I (RVPH) | 0.1 | $646k | 505k | 1.28 |
|
|
| Augmedix (AUGX) | 0.1 | $499k | -46% | 567k | 0.88 |
|
| X4 Pharmaceuticals (XFOR) | 0.1 | $468k | 807k | 0.58 |
|
|
| Tela Bio (TELA) | 0.1 | $460k | 98k | 4.70 |
|
|
| Alpha Teknova (TKNO) | 0.1 | $406k | 297k | 1.37 |
|
|
| Xeris Pharmaceuticals (XERS) | 0.0 | $227k | 101k | 2.25 |
|
Past Filings by Parkman Healthcare Partners
SEC 13F filings are viewable for Parkman Healthcare Partners going back to 2019
- Parkman Healthcare Partners 2024 Q2 filed Aug. 14, 2024
- Parkman Healthcare Partners 2024 Q1 filed May 15, 2024
- Parkman Healthcare Partners 2023 Q3 filed Nov. 14, 2023
- Parkman Healthcare Partners 2023 Q2 filed Aug. 11, 2023
- Parkman Healthcare Partners 2023 Q1 filed May 12, 2023
- Parkman Healthcare Partners 2022 Q4 filed Feb. 13, 2023
- Parkman Healthcare Partners 2022 Q3 filed Nov. 14, 2022
- Parkman Healthcare Partners 2022 Q2 filed Aug. 12, 2022
- Parkman Healthcare Partners 2022 Q1 filed May 13, 2022
- Parkman Healthcare Partners 2021 Q4 filed Feb. 11, 2022
- Parkman Healthcare Partners 2021 Q3 filed Nov. 12, 2021
- Parkman Healthcare Partners 2021 Q2 filed Aug. 13, 2021
- Parkman Healthcare Partners 2021 Q1 filed May 14, 2021
- Parkman Healthcare Partners 2020 Q4 filed Feb. 12, 2021
- Parkman Healthcare Partners 2020 Q3 filed Nov. 13, 2020
- Parkman Healthcare Partners 2020 Q2 filed Aug. 13, 2020